Company / Net Income
ABEONA THERAPEUTICS INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$71.2M
FY2025
5-year range
-$84.9M / $71.2M
FY2021-FY2025
Trend
+231.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed +231% YoY in FY2025, a notable deviation from the 9-year average annual change of -10%.
Based on SEC 10-K filings.
$71M in FY2025.
Improved from -$40M to $71M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 231.4% year-over-year.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.2M | +231.4% |
| FY2024 | -$54.2M | -36.5% |
| FY2023 | -$39.7M | +53.3% |
| FY2022 | -$84.9M | -0.8% |
| FY2021 | -$84.2M | -10.4% |
| FY2020 | -$76.3M | -179.2% |
| FY2019 | -$27.3M | +51.8% |
| FY2018 | -$56.7M | -107.4% |
| FY2017 | -$27.3M | -88.1% |
| FY2016 | -$14.5M | +45.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026